Molecular profiling and matched targeted treatment in cholangiocarcinoma: Results from the Italian dataset (ANITA).

Saved in:
Bibliographic Details
Title: Molecular profiling and matched targeted treatment in cholangiocarcinoma: Results from the Italian dataset (ANITA).
Authors: Genovesi V; Unit of Medical Oncology 2, Department of Oncology, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy., Salani F; Department of Translational Research and of New Surgical and Medical Technologies, University of Pisa, Pisa, Italy; School of Life, Health and Chemical Sciences, The Open University, Walton Hall, Milton Keynes, MK7 6AA, United Kingdom., Rimini M; Department of Oncology, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute Hospital, Milan, Italy., Rizzato MD; Medical Oncology 1, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy., Pressiani T; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano (Milan), Italy., Pircher C; Medical Oncology, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan, Italy., Salvatore L; Medical Oncology, Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; Medical Oncology, Università Cattolica del Sacro Cuore, Rome, Italy., Antonuzzo L; Clinical Oncology Unit, Careggi University Hospital, Florence, Italy; Department of Experimental and Clinical Medicine, University of Florence, Italy., Silvestro L; Experimental Clinical Abdominal Oncology Unit, Istituto Nazionale Tumori-IRCCS Fondazione G. Pascale, Naples, Italy., Daniele B; UOC Oncology, Ospedale del Mare, Naples, Italy., Leone F; Oncology Department, Ospedale degli Infermi, Ponderano (Biella), Italy., Vivaldi C; Unit of Medical Oncology 2, Department of Oncology, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy; Department of Translational Research and of New Surgical and Medical Technologies, University of Pisa, Pisa, Italy., Camera S; Department of Oncology, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute Hospital, Milan, Italy., Balsano R; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano (Milan), Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (Milan), Italy., Bergamo F; Medical Oncology 1, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy., Niger M; Medical Oncology, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan, Italy., Foti S; Department of Oncology, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute Hospital, Milan, Italy., Tesini G; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano (Milan), Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (Milan), Italy., Di Paolo G; Medical Oncology 1, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy; Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy., Rossari F; Department of Oncology, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute Hospital, Milan, Italy., Sperotto S; Medical Oncology 1, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy; Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy., Masi G; Unit of Medical Oncology 2, Department of Oncology, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy; Department of Translational Research and of New Surgical and Medical Technologies, University of Pisa, Pisa, Italy., Lonardi S; Medical Oncology 1, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy., Rimassa L; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano (Milan), Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (Milan), Italy., Casadei-Gardini A; Department of Oncology, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute Hospital, Milan, Italy., Fornaro L; Unit of Medical Oncology 2, Department of Oncology, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy. Electronic address: lorenzo.fornaro@gmail.com.
Source: Journal of hepatology [J Hepatol] 2026 May; Vol. 84 (5), pp. 933-945. Date of Electronic Publication: 2025 Dec 27.
Publication Type: Journal Article; Observational Study; Multicenter Study
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8503886 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0641 (Electronic) Linking ISSN: 01688278 NLM ISO Abbreviation: J Hepatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1600-0641
DOI:10.1016/j.jhep.2025.12.016